Experimental Hematology
Volume 38, Issue 8 , Pages 696-706, August 2010

FET family proto-oncogene Fus contributes to self-renewal of hematopoietic stem cells

  • Takeaki Sugawara

      Affiliations

    • Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
    • Division of Hematology, Chiba University Hospital, Chiba, Japan
    • Division of Transfusion and Cell Processing, Chiba University Hospital, Chiba, Japan
  • ,
  • Hideyuki Oguro

      Affiliations

    • Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  • ,
  • Masamitsu Negishi

      Affiliations

    • Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
  • ,
  • Yohei Morita

      Affiliations

    • Division of Stem Cell Therapy, Center for Stem Cell Biology and Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
  • ,
  • Hitoshi Ichikawa

      Affiliations

    • Genetics Division, National Cancer Center Research Institute, Tokyo, Japan
  • ,
  • Toru Iseki

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
    • Division of Hematology, Chiba University Hospital, Chiba, Japan
    • Division of Transfusion and Cell Processing, Chiba University Hospital, Chiba, Japan
  • ,
  • Osamu Yokosuka

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
  • ,
  • Hiromitsu Nakauchi

      Affiliations

    • Division of Stem Cell Therapy, Center for Stem Cell Biology and Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
    • Nakauchi Stem Cell and Organ Regeneration Project, JST, ERATO, Tokyo, Japan
  • ,
  • Atsushi Iwama

      Affiliations

    • Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
    • CREST, Sanbancho, Chiyoda-ku, Tokyo, Japan
    • Corresponding Author InformationOffprint requests to: Atsushi Iwama, M.D., Ph.D. Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan

Received 21 January 2010; received in revised form 7 April 2010; accepted 13 April 2010. published online 21 April 2010.

Objective

Fus is the gene for a member of the FET family of RNA-binding proteins often involved in chromosomal translocations to generate oncogenic fusion genes in human cancers. Fus participates in multiple cellular functions, including RNA processing and transport, transcriptional regulation, and genome integrity. However, its role in hematopoiesis remains obscure. In this study, we examined its role in the self-renewal of hematopoietic stem cells (HSCs).

Materials and Methods

HSCs in Fus−/− fetal livers were analyzed for proliferative capacity in vitro and long-term repopulating capacity in recipient mice. Radiation sensitivity of Fus−/− HSCs was evaluated in recipient mice repopulated by Fus−/− fetal liver cells.

Results

Fus−/− fetal livers developed normally, except for a mild reduction in numbers of hematopoietic stem and progenitor cells compared to wild-type. The proliferation and differentiation of Fus−/− hematopoietic progenitors were normal in vitro. However, the number of colony-forming cells present in long-term cocultures of Fus−/− hematopoietic progenitors and stromal cells was significantly reduced. Fus−/− HSCs had an impaired long-term repopulating capacity and failed to repopulate in tertiary recipient mice. Fus−/− HSCs were highly susceptible to radiation both in vitro and in vivo and showed retardation of radiation-induced DNA damage repair.

Conclusion

Our findings define Fus as a novel regulator of self-renewal and radioprotection of HSCs and also implicate it in stress-resistance and maintenance of the genomic integrity of HSCs.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(10)00149-9

doi:10.1016/j.exphem.2010.04.006

Experimental Hematology
Volume 38, Issue 8 , Pages 696-706, August 2010